Fluticasone-salmeterol 115-21 12GM
Ended Awarded
- Contract number
- SPE2DB25FTTR0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,454
Award facts
- Contract value 100% obligated
- $16,454.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,454.39 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Fluticasone-Salmeterol 115-21 12GM pharmaceutical products. This non-set-aside, competitively awarded delivery order features firm fixed-price pricing and is scheduled for ultimate completion on August 6, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as the prime contractor and fulfills federal medical procurement needs across the military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC represents a comprehensive global pharmaceutical support vehicle that enables the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this flexible contract mechanism, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with future procurement anticipated under DLA's planned Pharmaceutical Prime Vendor Global Program Generation V, which is expected to involve multiple regional awards to ensure competitive supply across the defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FTTR0?
SPE2DB25FTTR0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FTTR0 worth?
The government has obligated $16,454 on SPE2DB25FTTR0.
Is contract SPE2DB25FTTR0 an order under another contract?
Yes. SPE2DB25FTTR0 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FTTR0 competed?
The extent of competition for SPE2DB25FTTR0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award